Anogenital cancers testing in Regalbuto

Find health labs to test for Anogenital cancers in Regalbuto and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Pasteur Laboratorio Analisi Cliniche

Via Vittorio Emanuele, 117, 95033 Biancavilla CT, Italia

12.5 km

Unverified

See Details

Pap Test by Casa della Salute

Largo Milite Ignoto, 5D, 95040 Raddusa CT, Italia

13.8 km

Unverified

See Details

Pap Test by Franceschini Stefano

Via San Michele Arcangelo, 8P, 95030 Sant'Agata Li Battiati CT, Italia

24.9 km

Unverified

See Details

Pap Smear by Polilab Srl

Via Etnea, 509, 95125 Catania CT, Italia

26.5 km

Unverified

See Details

Pap Test by Laboratorio Analisi Baiata

Via Luigi Capuana, 1, 97014 Ispica RG, Italia

61.6 km

Unverified

A Pap Smear costs €80.00

See Details

Pap Test by Abc Analisi Cliniche srl Laboratorio Lo presti

Via Pietro Nenni 13, 92100 Agrigento Agrigento, Italy

62.6 km

Verified

See Details

Pap Test by Centro Medico Meditel Saronno

Via Enrico Alliata, 1, 90014 Casteldaccia PA, Italia

66.6 km

Verified

See Details

Pap Smear by Interlab - Laboratorio di Analisi Cliniche e di Biologia Molecolare

Via Giacomo Alagna 2, 90123 Palermo Palermo, Italy

76.7 km

Verified

See Details

Pap Smear by Laboratorio Analisi Cliniche Uditore S. R. L.

Via Suor Maria Dolores di Majo, 13, 90145 Palermo PA, Italia

76.7 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Dante Alighieri 39, Palmi, RC, Italia 89015 Palmi (RC)

81.9 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.